All individuals in MeSH

Label Id Description
Drug Labeling D004348 [Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information. ]
Drug Liberation D065546 [Release of drugs from DOSAGE FORMS into solution. ]
Drug Misuse D000076064 [Use of a drug for a purpose not consistent with legal or medical guidelines. ]
Drug Monitoring D016903 [The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. ]
Drug Overdose D062787 [Accidental or deliberate use of a medication or street drug in excess of normal dosage. ]
Drug Packaging D004349 [Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. ]
Drug Partial Agonism D054333 [Drug agonism involving selective binding but reduced effect. This can result in some degree of DRUG ANTAGONISM. ]
Drug Prescriptions D011307 [Directions written for the obtaining and use of DRUGS. ]
Drug Recalls D056736 [Removal of a drug from the market due to a problem occurring in the manufacture or distribution of the product. ]
Drug Repositioning D058492 [Research involving drugs, small molecules and biologics whose development was abandoned before they could be approved by the UNITED STATES FOOD AND DRUG ADMINISTRATION, to study their potential therapeutic uses. , The deliberate and methodical practice of finding new applications for existing drugs. ]
Drug Residues D004350 [Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment. ]
Drug Resistance D004351 [Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. ]
Drug Resistance, Bacterial D024881 [The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). ]
Drug Resistance, Fungal D025141 [The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation. ]
Drug Resistance, Microbial D004352 [The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). ]
Drug Resistance, Multiple D018432 [Simultaneous resistance to several structurally and functionally distinct drugs. ]
Drug Resistance, Multiple, Bacterial D024901 [The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). ]
Drug Resistance, Multiple, Fungal D026141 [The ability of fungi to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutations. ]
Drug Resistance, Multiple, Viral D024921 [The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation. ]
Drug Resistance, Neoplasm D019008 [Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures. ]